期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

利用MTT比色法建立快速检测化疗后骨肉瘤细胞活性的方法

A rapid colorimetric assay for viability of osteosarcoma cells after chemotherapy
下载PDF
导出
摘要 目的建立一种以MTT结晶盐的浓度与化疗后骨肉瘤残存活细胞之间的定量关系分析肿瘤坏死率、快速检测化疗后骨肉瘤细胞活性的方法。方法用MTT比色法检测不同浓度(数量)骨肉瘤细胞悬液时OD值的变化,观察及统计分析活细胞数量与OD值关系。结果骨肉瘤细胞甲月赞产物溶液的吸光值A570与肿瘤细胞数呈线性关系。结论该方法可以用来检测骨肉瘤细胞的活性,具有快速、简便、灵敏的特点,是一种准确的利用定量关系分析化疗后骨肉瘤肿瘤坏死率方法。 Objective To introduce a rapid colorimetric method for assessing the viability of osteosarcoma cells after chemotherapy. Methods Colorimetric assay and automatic microplate scanning spectrophotometer were used for assaying the viability of osteosarcoma cells. Results Close correlation was found between the absorbance at 570 nm of the formazan products and the number of viable osteosarcoma cells. Conclusion An effective, sensitive and convenient colorimetric assay has been established to assess the survival of osteosarcoma cells following chemotherapy.
作者 陈强 张进华 陈建庭 史占军 邓永健
机构地区 南方医科大学南方医院脊柱骨病外科 南方医科大学南方医院病理科
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第12期2490-2491,共2页 Journal of Southern Medical University
基金 南方医院院长基金(20060009)
关键词 骨肉瘤细胞 比色法 MTT osteosarcoma cells colorimetric assay MTT assay
分类号 R738.1 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1Mosmann T. Rapid colorimetric assay for cell growth and survival: application to proliferation and cytotoxicity assays [J]. J Immurlol Methods, 1983, 65(2): 55-63.
  • 2Heeg K, Reimann J, Kabelitz D, et al. A rapid colorimetric assay for the determination of IL22 producing helper T cell frequencies [J]. J Immunol Methods, 1985, 77(2): 237-46.
  • 3方翼,王睿,刘皈阳.MTT比色法在检测细胞因子和抗菌药物中的应用[J].中国临床药理学与治疗学杂志,1997,2(1):65-67. 被引量：2
  • 4Bacci G. Histologic response of high-grade nonmetastatic osteosarcoma of the extremity to chemotherapy [J]. Clin Orthop, 2001, (386): 186-96.
  • 5Huvos AG. Bone tumours, diagnosis, treatment and prognosis [M]. Philadelphia: WB Saunders, 1991: 85-155.
  • 6李健,郭卫,杨荣利,曲华毅,樊瑞峰.骨肉瘤患者SAP值的测定及其临床意义[J].中国骨肿瘤骨病,2004,3(4):200-205. 被引量：1

二级参考文献13

  • 1孙绩耀,郭庆福,庄汉澜.两种检测细胞活性的改良MTT法[J].军事医学科学院院刊,1993,17(1):61-64. 被引量：16
  • 2[1]Szendroi M,Papai Z,Koos R,et al. Limb - saving surgery, survival,and prognostic factors for osteosarcoma: the Hungarian experience. J Surg Oncol. 2000,73:87 -94.
  • 3[2]Ozaki T,Flege S,Kevric M,et al. Osteosarcoma of the pelvis:experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol.2003,21:334 - 341.
  • 4[3]Smeland S, Muller C, Alvegard TA, et al. Scandinavian Sarcoma Group Osteosarcoma Study SSG Ⅷ: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer,2003 Mar;39:488 -494.
  • 5[4]Bacci G, Picci P, Orlandi M, et al. Prognostic value of serum alkaline phosphatase in osteosarcoma. Tumori, 1987,73:331 - 336.
  • 6[5]Bacci G, Picci P, Ferrari S,et al. Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy. Cancer, 1993,71:1224 - 1230.
  • 7[6]Bacci G, Longhi A, Ferrari S,et al. Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. Oncology Reports, 2002,9:171 - 175.
  • 8[7]Stokkel MP, Linthorst MF, Borm JJ, et al. A reassessment of bone scintigraphy and commlnly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma. J Cancer Res Clin Oncol, 2002,128:393 - 399.
  • 9[8]Link M P, Gooren A M,Horowitz M,et al. Adjuvant chemotherapy of high grade osteosarma of the extremity. Updated results of the multiinstitutional osteosarcoma study. Clin Orthop, 1996,270:8 - 14.
  • 10[9]Bacci G,Ferrari S,Delepine N,et al. Predictive factors of histolohic response to primary chemotherapy in osteosarcoma of the extremity:study of 272 patients preoperatively treated with high - dose methotrexate, doxorubicin, and cisplatin. J Clin Oncol, 1998,16:658 -663.

共引文献1

南方医科大学学报
2009年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部